Evidence map›Paper›PMID 31893212›Full record

ArticleOpen forum infectious diseases2019

Markers of CNS Injury in Adults Living With HIV With CSF HIV Not Detected vs Detected <20 Copies/mL.

Shelli F Farhadian, Hetal Mistry, Tobias Kirchwey, Jennifer Chiarella, Rachela Calvi, Michelle Chintanaphol, Payal Patel, Marie L Landry, Kevin Robertson, Serena S Spudich

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Preliminary In Vivo Evidence of Reduced Synaptic Density in Human Immunodeficiency Virus (HIV) Despite Antiretroviral Therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  4. Article
  5. Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Shelli F FarhadianSection of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Hetal MistryDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Tobias KirchweyDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Jennifer ChiarellaDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Rachela CalviDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Michelle ChintanapholDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Payal PatelDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Marie L LandryDepartments of Laboratory Medicine and Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Kevin RobertsonDepartment of Neurology, University of North Carolina, Chapel Hill, North Carolina, USA.
Serena S SpudichDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Yale University · USUniversity of North Carolina at Chapel Hill · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Training Program in Geriatric Clinical Epidemiology and Aging-Related ResearchT32AG019134 · NIA · YALE UNIVERSITY · PI Terri R. Fried · 2001 to 2026
$7.5M
TRAINING IN THE PATHOGENESIS OF INFECTIOUS DISEASEST32AI007517 · NIAID · YALE UNIVERSITY · PI Jaimie Meyer, Albert C Shaw · 1997 to 2026
$6.1M
Understanding the cellular basis for persistent immune activation in the central nervous system during virologically suppressed HIVK23MH118999 · NIMH · YALE UNIVERSITY · PI FARHADIAN, SHELLI · 2018 to 2021
$770k
NCATS NIH HHS UL1 TR001863NIAID NIH HHS T32 AI007517NIA NIH HHS T32 AG019134NIMH NIH HHS K23 MH118999
6 · The paper itself

Abstract

The presence of quantifiable HIV RNA in cerebrospinal fluid (CSF) during antiretroviral therapy (ART) can associate with central nervous system (CNS) pathology, but the significance of RNA detected below the limit of quantification (LOQ) on a standard assay during ART remains unknown. We compared CNS parameters between individuals with CSF RNA detected below the LOQ (20 copies/mL) with those with HIV RNA not detected. Detection of CSF HIV RNA associated with decreased blood-brain barrier integrity and with decreased executive function, but not with CNS immune activation or poorer performance in overall neuropsychological testing.

Indexed as

antiretroviral therapyblood–brain barrierHIVviral persistence

Identifiers

PMID31893212
PMCPMC6934883
OpenAlexW2997718720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.